Medicare Renal Dialysis Facility Manual (Non-Hospital Operated), Section 319.4, Billing for Sodium Ferric Gluconate Complex in Sucrose Injection
Guidance for coverage, billing and payment of sodium ferric gluconate complexing sucrose injection for first line treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoietin therapy
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: November 03, 2000
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.